(AOF) – Implanet revealed turnover for its first quarter up 1% to 2.22 million euros. The medtech specializing in implants intended for orthopedic surgery and in the distribution of technological medical equipment reported good momentum in its activity in France, growing by 10%, or a turnover of 1.03 million euros over the period. In the United States, activity fell by 32%. At the end of March 2024, Implanet had cash of 2.24 million euros.
In terms of prospects, the medtech intends in particular to “revitalize its presence in the United States” while strengthening “market dynamics and product offerings”.
Implanet, which announced on February 2 that it had raised funds worth 5.5 million euros, will publish its revenue for the first half of 2024 on July 9.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
